Skip to main content

Table 2 Psychiatrist-reported CGI severity of illness

From: Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey

 

Overall

US

France

Spain

Japan

China

LAI

Non-LAI

LAI

Non-LAI

LAI

Non-LAI

LAI

Non-LAI

LAI

Non-LAI

LAI

Non-LAI

Number of patients

1108

3042

241

842

333

450

410

392

83

416

52

943

CGI severity of illness

***

 

***

         

Normal, not ill at all, n (%)

25 (2.3)

115 (3.8)

4 (1.7)

28 (3.3)

3 (0.9)

6 (1.3)

10 (2.5)

10 (2.6)

7 (8.4)

29 (7.0)

1 (1.9)

42 (4.5)

Borderline mentally ill, n (%)

91 (8.2)

366 (12.0)

10 (4.2)

119 (14.1)

27 (8.1)

34 (7.6)

45 (11.3)

36 (9.2)

8 (9.6)

55 (13.2)

1 (1.9)

122 (12.9)

Mildly ill, n (%)

241 (21.8)

1000 (32.9)

47 (19.5)

227 (27.0)

51 (15.3)

88 (19.6)

85 (21.3)

89 (22.8)

29 (34.9)

145 (34.9)

29 (55.8)

451 (47.8)

Moderately ill, n (%)

391 (35.3)

998 (32.8)

102 (42.3)

299 (35.5)

108 (32.4)

153 (34.0)

134 (33.6)

151 (38.6)

28 (33.7)

157 (37.7)

19 (36.5)

238 (25.2)

Markedly ill, n (%)

246 (22.2)

399 (13.1)

55 (22.8)

121 (14.4)

102 (30.6)

116 (25.8)

78 (19.6)

73 (18.7)

9 (10.8)

20 (4.8)

2 (3.9)

69 (7.3)

Severely ill, n (%)

97 (8.8)

144 (4.7)

21 (8.7)

40 (4.8)

40 (12.0)

48 (10.7)

34 (8.5)

28 (7.2)

2 (2.4)

7 (1.7)

0 (0.0)

21 (2.2)

Among the most extremely ill patients, n (%)

17 (1.5)

20 (0.7)

2 (0.8)

8 (1.0)

2 (0.6)

5 (1.1)

13 (3.3)

4 (1.0)

0 (0.0)

3 (0.7)

0.0

0.0

  1. ***p≤0.0001
  2. Blank cells indicate no change in sample size from the overall number of patients presented at the outset of the table. Where sample size varies, ‘n’ number is stated
  3. CGI Clinical Global Impression, LAI long-acting injectable, US United States